Nkarta, Inc. (NKTX)
2.69
-0.02
(-0.74%)
USD |
NASDAQ |
Sep 01, 16:00
2.69
0.00 (0.00%)
After-Hours: 17:23
Nkarta Total Long Term Debt (Quarterly) : 66.26M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.26M |
| March 31, 2026 | 67.92M |
| December 31, 2025 | 69.53M |
| September 30, 2025 | 70.26M |
| June 30, 2025 | 71.63M |
| March 31, 2025 | 72.96M |
| December 31, 2024 | 74.22M |
| September 30, 2024 | 78.69M |
| June 30, 2024 | 80.04M |
| March 31, 2024 | 81.10M |
| December 31, 2023 | 82.27M |
| September 30, 2023 | 83.41M |
| June 30, 2023 | 84.45M |
| March 31, 2023 | 85.54M |
| December 31, 2022 | 78.68M |
| Date | Value |
|---|---|
| September 30, 2022 | 78.10M |
| June 30, 2022 | 69.41M |
| March 31, 2022 | 66.74M |
| December 31, 2021 | 9.975M |
| September 30, 2021 | 10.35M |
| June 30, 2021 | 10.41M |
| March 31, 2021 | 10.27M |
| December 31, 2020 | 7.517M |
| September 30, 2020 | 7.659M |
| June 30, 2020 | 7.826M |
| March 31, 2020 | 5.576M |
| December 31, 2019 | 65.60M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Theriva Biologics, Inc. | 3.028M |
| Unicycive Therapeutics, Inc. | 0.055M |
| OnKure Therapeutics, Inc. | 0.59M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |